Commentary: Microvesicles: A target for personalized medicine following coronary artery bypass grafting.

J Thorac Cardiovasc Surg

Division of Cardiac Surgery, The University of Pittsburgh Medical Center, Pittsburgh, Pa. Electronic address:

Published: February 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2020.11.021DOI Listing

Publication Analysis

Top Keywords

commentary microvesicles
4
microvesicles target
4
target personalized
4
personalized medicine
4
medicine coronary
4
coronary artery
4
artery bypass
4
bypass grafting
4
commentary
1
target
1

Similar Publications

Extracellular vesicles (EVs) are cell-released, heterogenous nanoparticles that play important roles in (patho)physiological processes through intercellular communication. EVs are often depicted as having a single lipid bilayer, but many studies have demonstrated the existence of multilayered EVs. There has been minimal inquiry into differences between unilamellar and multilamellar EVs in terms of biogenesis mechanisms and functional effects.

View Article and Find Full Text PDF

Reply to Trimaille et al.

Am J Physiol Heart Circ Physiol

October 2021

Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!